Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience...
14 insider sale filings on record · latest filing 2026-04-17.
No open-market insider purchases (SEC Form 4 code P) on record for WHWK.